MHRA launches call for evidence on AI regulation in UK healthcare sector
The commission brings together experts, clinicians, patient advocates, and regulators to advise the MHRA on the AI regulation.
Healthcare
Raising the bar: can higher drug spending in the UK deliver for pharma and patients?
What’s been agreed at this year’s World Health Assembly?
Streeting promises UK pharma quick action on VPAG frustration
UK life sciences venture capital funding lags behind
Public health strategies skip patients with rare diseases, says UK study
Fourth person receives eGenesis’ gene-edited pig kidney transplant
Neumora shares sink following Phase III flop in MDD
